Compugroup Medical (COP) Given a €63.00 Price Target by Deutsche Bank Analysts

Compugroup Medical (ETR:COP) received a €63.00 ($77.78) target price from analysts at Deutsche Bank in a report issued on Monday. The brokerage presently has a “buy” rating on the stock. Deutsche Bank’s price target would indicate a potential upside of 33.70% from the company’s previous close.

Several other equities analysts have also recently weighed in on the company. Baader Bank set a €52.00 ($64.20) price objective on Compugroup Medical and gave the company a “neutral” rating in a report on Thursday, November 9th. Warburg Research set a €56.00 ($69.14) target price on shares of Compugroup Medical and gave the company a “buy” rating in a research note on Friday, November 10th. Commerzbank set a €62.00 ($76.54) target price on shares of Compugroup Medical and gave the company a “buy” rating in a research note on Monday, November 13th. Berenberg Bank set a €53.00 ($65.43) target price on shares of Compugroup Medical and gave the company a “neutral” rating in a research note on Friday, November 10th. Finally, HSBC set a €60.00 ($74.07) target price on shares of Compugroup Medical and gave the company a “buy” rating in a research note on Friday, January 26th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of €57.57 ($71.08).

Compugroup Medical (ETR:COP) opened at €47.12 ($58.17) on Monday. The firm has a market capitalization of $2,500.00 and a PE ratio of 57.46. Compugroup Medical has a 1-year low of €37.51 ($46.31) and a 1-year high of €60.30 ($74.44).

ILLEGAL ACTIVITY NOTICE: This report was first posted by American Banking News and is owned by of American Banking News. If you are accessing this report on another website, it was stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this report can be accessed at https://www.americanbankingnews.com/2018/02/12/compugroup-medical-cop-given-a-63-00-price-target-by-deutsche-bank-analysts.html.

About Compugroup Medical

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply